LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
REYN
Reynolds Consumer Products Inc.
REYN has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
REYN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
REYN's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
REYN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $23.30 | -4.9% |
| Forward | 15x | $24.50 | — |
| Current | 16x | $24.50 | — |
| Fair | 18x | $27.78 | +13% |
| Expensive | 22x | $34.23 | +40% |
Historical ranges are pointers, not guarantees.
REYN's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 15x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
REYN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect REYN's profitability to weaken, with its earnings and revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
REYN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.64 | +7.2% |
| Q3 2026 | $1.53 | +5.5% |
| Q2 2026 | $1.63 | +10% |
| Q1 2026 | $1.56 | -1.9% |
| Q4 2025 | $1.43 | -14% |
| Q3 2025 | $1.45 | -17% |
| Q2 2025 | $1.48 | -13% |
| Q1 2025 | $1.59 | +1.3% |
| Q4 2024 | $1.67 | +18% |
REYN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over REYN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
REYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $944M | +1.4% |
| Q2 2026 | $944M | +0.6% |
| Q1 2026 | $877M | +7.2% |
| Q4 2025 | $1B | +1.4% |
| Q3 2025 | $931M | +2.3% |
| Q2 2025 | $938M | +0.9% |
| Q1 2025 | $818M | -1.8% |
| Q4 2024 | $1B | +1.4% |
REYN's revenue grew through 2021 and has held roughly level since: $944M last quarter, up 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.1% | -2.9 points |
| Q2 2026 | 12% | +2.1 points |
| Q1 2026 | 8.8% | +3.6 points |
| Q4 2025 | 15% | -0.7 points |
| Q3 2025 | 11% | -1.5 points |
| Q2 2025 | 10% | -2.1 points |
| Q1 2025 | 5.1% | -2.7 points |
| Q4 2024 | 15% | -2.2 points |
REYN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
REYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9M | -81% |
| Q2 2026 | $45M | -12% |
| Q1 2026 | $27M | +59% |
| Q4 2025 | $200M | +42% |
| Q3 2025 | $48M | -48% |
| Q2 2025 | $51M | -22% |
| Q1 2025 | $17M | -76% |
| Q4 2024 | $141M | -27% |
REYN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
REYN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.7x | Moderate |
REYN's net debt is about 2.7 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
REYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 50.9 | Neutral |
REYN's weekly RSI is 56 (neutral) and its Stochastic is 51 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
REYN PE vs Consumer Cyclical Sector
| Metric | REYN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 31 | 48 | 17 pts below |
REYN is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
REYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.0 | 6.5% above |
| 20 week MA | $24.1 | 1.6% above |
| 50 week MA | $23.4 | 4.9% above |
| 100 week MA | $23.6 | 3.9% above |
| 200 week MA | $25.8 | 5% below |
REYN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
REYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $30.5 | +6.8% |
| 2021 | $30.5 | $30.3 | -0.6% |
| 2022 | $30.3 | $30.4 | +0.2% |
| 2023 | $30.4 | $26.8 | -12% |
| 2024 | $26.8 | $27.3 | +1.7% |
| 2025 | $27.3 | $23.3 | -15% |
| 2026 YTD | $23.3 | $24.5 | +5.2% |
REYN has the edge over LCID on returns for 2026, with the stronger performance.